EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research

Concepción J Puerta, Adriana Cuellar, Paola Lasso, Jose Mateus, John M Gonzalez

Frontiers in Cellular and Infection Microbiology · 04.01.2023 · 12

DOI: 10.3389/fcimb.2022.1075717 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 04.01.2023. Verfasst von Concepción J Puerta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Parasitology, Infectious Diseases Group, Department of Microbiology, School of Sciences, Pontificia Universidad Javeriana, Bo…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Chagas Cardiomyopathy, Persistent Infection, Trypanosoma cruzi. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pontificia Universidad Javeriana, Departamento Administrativo de Ciencia, Tecnología e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trypanosoma cruzi , the causal agent of Chagas disease, has coexisted with humans for thousands of years. Therefore, the parasite has developed several mechanisms of antigenic variability that has allowed it to live inside the cells and evade the host immune response. Since T. cruzi displays an intracellular cycle-stage, our research team focused on providing insights into the CD8 + T cells immune response in chronic Chagas cardiomyopathy. We began our work in the 2000s studying parasite antigens that induce natural immune responses such as the KMP11 protein and TcTLE, its N-terminal derived peptide. Different approaches allowed us to reveal TcTLE peptide as a promiscuous CD8 + T cell epitope, able of inducing multifunctional cellular immune responses and eliciting a humoral response capable of decreasing parasite movement and infective capacity. Next, we demonstrated that as the disease progresses, total CD8 + T cells display a dysfunctional state characterized by a prolonged hyper-activation state along with an increase of inhibitory receptors (2B4, CD160, PD-1, TIM-3, CTLA-4) expression, an increase of specific terminal effector T cells (T TE ), a decrease of proliferative capacity, a decrease of stem cell memory (T SCM ) frequency, and a decrease of CD28 and CD3ζ expression. Thus, parasite-specific CD8 + T cells undergo clonal exhaustion, distinguished by an increase in late-differentiated cells, a mono-functional response, and enhanced expression of inhibitory receptors. Finally, it was found that anti-parasitic treatment induces an improved CD8 + T cell response in asymptomatic individuals, and a mouse animal model led us to establish a correlation between the quality of the CD8 + T cell responses and the outcome of chronic infection. In the future, using OMICs strategies, the identification of the specific cellular signals involved in disease progression will provide an invaluable resource for discovering new biomarkers of progression or new vaccine and immunotherapy strategies. Also, the inclusion of the TcTLE peptide in the rational design of epitope-based vaccines, the development of immunotherapy strategies using T SCM or the blocking of inhibitory receptors, and the use of the CD8 + T cell response quality to follow treatments, immunotherapies or vaccines, all are alternatives than could be explored in the fight against Chagas disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesChagas CardiomyopathyPersistent InfectionTrypanosoma cruziAnimalsHumansMiceEpitopes, T-Lymphocyte

Stichwörter der Autor:innen

CD8+ T cellChagas cardiomyopathyChagas diseaseTcTLE peptideTrypanosoma cruziimmune response

Substanzen

Epitopes, T-Lymphocyte

Autor:innen und Institutionen

  • Laboratory of Molecular Parasitology, Infectious Diseases Group, Department of Microbiology, School of Sciences, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Clinical Laboratory Sciences Group, Department of Microbiology, School of Sciences, Pontificia Universidad Javeriana, Bogotá, Colombia.
  • Group of Biomedical Sciences, School of Medicine, Universidad de Los Andes, Bogotá, Colombia.

Förderung

  • Pontificia Universidad Javeriana
  • Departamento Administrativo de Ciencia, Tecnología e Innovación

Zitieren

APA

Puerta, C. J., Cuellar, A., Lasso, P., Mateus, J., & Gonzalez, J. M. (2023). Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research. Frontiers in Cellular and Infection Microbiology, 12. https://doi.org/10.3389/fcimb.2022.1075717

Vancouver

Puerta CJ, Cuellar A, Lasso P, Mateus J, Gonzalez JM. Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research. Frontiers in Cellular and Infection Microbiology. 2023;12. doi:10.3389/fcimb.2022.1075717

BibTeX
@article{Puerta2023,
  author = {Puerta, Concepción J and Cuellar, Adriana and Lasso, Paola and Mateus, Jose and Gonzalez, John M},
  title = {Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {12},
  doi = {10.3389/fcimb.2022.1075717}
}
Kostenlos starten →